Asia-Pacific In-Vitro Fertilization Services Market - Opportunities and Forecasts, 2014 - 2020

  • ID: 3617523
  • Report
  • Region: Asia Pacific
  • 132 pages
  • Allied Analytics LLP
1 of 5
Asia-Pacific In-Vitro Fertilization Services Market is Expected to Reach $3.5 billion by 2020

FEATURED COMPANIES

  • Aster Fertility Clinic
  • City Fertility
  • IVF Namba Clinic
  • Iwaki Womens Clinic
  • Manipal Ankur
  • Ramathibodi Hospital
  • MORE


In-vitro fertilization is an assisted reproductive technology, which involves a series of procedures for treating infertility problems. It involves the fertilization of the ovum in-vitro, followed by implantation of the embryo into a womens uterus. The IVF technology is fast gaining pace in the Asia Pacific region, as the infertility rates are spiraling. In addition, the rapidly rising geriatric population is a major concern for countries with below average birth rates such as, Indonesia, Vietnam, Cambodia and Philippines. Also, the rising trends towards delaying pregnancy has steadily increased in China and many other countries, resulting in aging of the eggs, making it less suitable for fertilization. This in turn, has increased the need of IVF services. Moreover, the commercialization of cost-effective fertility treatments and significant growth in medical tourism across Asia-Pacific would offer lucrative opportunities in future. Furthermore, proactive initiatives for the development of novel IVF technologies would facilitate the dynamic growth of the Asia-Pacific IVF market.

The Asia-Pacific IVF services market was evaluated at $1.9 billion in 2014 and is estimated to garner $3.5 billion by 2020, registering a CAGR of 10.8% during the forecast period 20152020. This market is expected to witness significant growth during the forecast period on account of the delayed pregnancies, rising infertility rates due to dysfunctional lifestyles, environmental pollution, increasing disposable incomes and emergence of newer fertility tourism destinations. In addition, several academic institutions are collaborating with fertility hospitals and clinics to conduct extensive research & development activities, and provide more effective and better treatment facilities. The other factors, namely technological advancements, utilization of intra-cytoplasmic sperm injection (ICSI) technique and growing popularity of donor egg IVF methods would collectively boost the success rates of IVF cycles. However, factors such as high costs associated with the treatment, lack of favorable IVF reimbursement policies and lower health awareness, especially in the underdeveloped Asia-Pacific countries, such as Nepal and Myanmar, are the major factors hampering the market growth. In addition, ethical concerns regarding the parental rights are expected to have a restraining effect on the growth of the market.

The Asia-Pacific IVF services market is segmented on the basis of end users, cycles type and country-wise analysis. Based on the type of cycle performed, the market is categorized into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh IVF cycle is the largest revenue-generating segment, owing to increasing preference of IVF for infertility treatment. The end users market is categorized into fertility clinics, hospitals, surgical centers and clinical research institutes. In 2014, fertility clinics were the leading end user segments, accounting for about one-fifths of the overall market share.

Geographically, this market is segmented into India, China, Japan, Vietnam, Korea, Australia, New Zealand, Thailand, Malaysia, Indonesia, Philippines, Singapore, and other Asia-Pacific countries. In terms of revenue, Japan dominates the Asia-Pacific IVF market, owing to the large consumer base, rapid adoption of advanced technologies and availability of skilled workforce. However, the Indian IVF market is anticipated to register a promising CAGR of 14.7% during the forecast period. This is mainly supplemented by factors, such as the rising trend of fertility tourism, favorable regulation of surrogacy and donor services, and wide availability of IVF clinics. Based on number of cycles performed, Japan is the leading country, accounting for a major share of the market and is expected to maintain this trend throughout the forecast period. However, the India IVF market, in terms of number of cycles performed, is anticipated to grow at a promising CAGR of 16.3% during the study period.

KEY MARKET BENEFITS:

- This report provides an in-depth analysis of the Asia-Pacific IVF market across seven major countries along with cross sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period.
- It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the Asia-Pacific IVF market.
- This report comprehensively analyzes the market scenario across different countries in the Asia-Pacific region.
- The projections in this report are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2014 to 2020.
- Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.

ASIA-PACIFIC IN-VITRO FERTILIZATION SERVICES MARKET KEY SEGMENTS:

The Asia-Pacific IVF market is segmented on the basis of end users, cycle type and country:

By End Users (Value and Volume)

- Fertility clinics
- Hospitals
- Surgical centers
- Clinical research institutes

By Cycle Type, (Value and Volume)

- Fresh cycle (non-donor)
- Thawed IVF cycle (non-donor)
- Donor egg IVF cycles

By Cycle Type Country Level Analysis (Value and Volume)

- India
- China
- Japan
- Australia
- New Zealand
- Korea
- Thailand
- Singapore
- Malaysia
- Indonesia
- Philippines
- Vietnam
- Others
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aster Fertility Clinic
  • City Fertility
  • IVF Namba Clinic
  • Iwaki Womens Clinic
  • Manipal Ankur
  • Ramathibodi Hospital
  • MORE
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Coverage and limitations
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 ASIA PACIFIC IVF MARKET ANALYSIS

3.1 Market definition and scope
3.2 Overview
3.3 Drivers

3.3.1 Delay in family planning reduces fertility
3.3.2 Decline in birth rate
3.3.3 Emotional problems

3.4 Restraints
3.5 Asia Pacific embryo transfer market by country
3.6 Asia-Pacific fresh embryo transfersby country
3.7 Asia-Pacific frozen embryo transfers by country
3.8 Asia Pacific embryo transfer market by end users
3.9 Asia-Pacific embryo transfer market by cycle type
3.10 Company profile

3.10.1 Thermo Fisher Scientific Inc.
3.10.2 EMD Serono, Inc.

CHAPTER 4 CHINA EMBRYO TRANSFER MARKET

4.1 China embryo transfer market by end users
4.2 China embryo transfer market by cycle type
4.3 Drivers

4.3.1 Increased rate of infertility
4.3.2 Change in lifestyle

4.4 Restraints

4.4.1 Cost of living

4.5 Regulatory issues, legislations and authorities
4.6 Insurance reimbursement scenario
4.7 Company profile

4.7.1 Cook Medical, Inc.
4.7.2 Vitrolife AB
4.7.3 Centre for Reproductive Medicine
4.7.4 Reproductive and genetic Hospital Citic-Xiangya
4.7.5 Shenyang Hospital
4.7.6 Shandong Provincial Hospital

CHAPTER 5 INDIA EMBRYO TRANSFER MARKET

5.1 India embryo transfer market by end users
5.2 India embryo transfer market by cycle type
5.3 Drivers
5.4 Restraints
5.5 Regulatory issues, legislations and authorities
5.6 Insurance reimbursement scenario
5.7 Company profile

5.7.1 Sun Pharmaceutical Industries Ltd.
5.7.2 Trivector Origio Scientific Pvt. Ltd
5.7.3 Lab IVF Asia Pte. Ltd.
5.7.4 LG Life Sciences.
5.7.5 Cadila Healthcare Ltd. (Zydus Cadila group)
5.7.6 Bourn Hall Clinic
5.7.7 Morpheus IVF Fertility Center
5.7.8 Southend Fertility and IVF Centre
5.7.9 Nova IVI Fertility
5.7.10 Bloom Fertility Center
5.7.11 Manipal Ankur
5.7.12 Cloudnine

CHAPTER 6 KOREA EMBRYO TRANSFER MARKET

6.1 Korea embryo transfer market by end users
6.2 Korea embryo transfer market by cycle type
6.3 Drivers
6.4 Restraints
6.5 Regulatory issues, legislations and authorities
6.6 Insurance reimbursement scenario
6.7 Company Profiles

6.7.1 Cha General Hospital
6.7.2 Maria Fertility Hospital

CHAPTER 7 NEW ZEALAND EMBRYO TRANSFER MARKET

7.1 New Zealand embryo transfer market by end users
7.2 New Zealand embryo transfer market by cycle type
7.3 Drivers
7.4 Restraints
7.5 Regulatory issues, legislations and authorities
7.6 Insurance reimbursement scenario
7.7 Company Profiles

7.7.1 Fertility Associates
7.7.2 Fertility Plus
7.7.3 Reporomed

CHAPTER 8 AUSTRALIA EMBRYO TRANSFER MARKET

8.1 Australia embryo transfer market by end users
8.2 Australia embryo transfer market by cycle type
8.3 Drivers
8.4 Restraints

8.4.1 Emotional and physical stress
8.4.2 No guarantee
8.4.3 Surplus embryos

8.5 Regulatory issues, legislations and authorities

8.5.1 Common Law
8.5.2 Legislative responses to IVF
8.5.3 Non-legislative regulation for the practice of IVF

8.6 Insurance reimbursement scenario
8.7 Company profile

8.7.1 Genea Biomedx
8.7.2 Thermo Fisher Scientific Inc.
8.7.3 Virtus Health
8.7.4 Monash IVF
8.7.5 City Fertility
8.7.6 Flinders Fertility

CHAPTER 9 JAPAN EMBRYO TRANSFER MARKET

9.1 Japan embryo transfer market by end users
9.2 Japan embryo transfer market by cycle type
9.3 Drivers
9.4 Restraints
9.5 Regulatory issues, legislations and authorities
9.6 Insurance reimbursement scenario
9.7 Company profile

9.7.1 EMD Serono, Inc.
9.7.2 IVF Namba Clinic
9.7.3 Iwaki Womens Clinic
9.7.4 Sanno Hospital

CHAPTER 10 SOUTH-EAST ASIA EMBRYO TRANSFER MARKET

10.1 South-East Asia embryo transfer market
10.2 Singapore embryo transfer market

10.2.1 Singapore embryo transfer market by end users
10.2.2 Singapore embryo transfer market by cycle type
10.2.3 Drivers

10.2.3.1 Government funding and tax rebates for parents
10.2.3.2 Rising infertility rate
10.2.3.3 Increase in success rate

10.2.4 Restraints

10.2.4.1 High cost of IVF treatment and lower success rate

10.2.5 Regulatory issues, legislations and authorities
10.2.6 Insurance reimbursement scenario
10.2.7 Company profile

10.2.7.1 Irvine Scientific
10.2.7.2 Esco Technologies, Inc.
10.2.7.3 Leica Microsystems Gmbh

10.2.8 Company snapshot

10.2.8.1 NUH IVF Centre
10.2.8.2 Mount Elizabeth Fertility Center
10.2.8.3 Thomson Fertility Centre
10.2.8.4 Raffles Fertility Centre

10.3 Malaysia embryo transfer market

10.3.1 Malaysia embryo transfer market by end users
10.3.2 Malaysia embryo transfer market by cycle type
10.3.3 Drivers

10.3.3.1 Increase in government initiatives
10.3.3.2 Increase in the number of foreign patients
10.3.3.3 Decrease in rate of fertility and growing acceptability of IVF

10.3.4 Restraints
10.3.5 Regulatory issues, legislations and authorities
10.3.6 Insurance reimbursement scenario
10.3.7 Company Profiles

10.3.7.1 Subang Fertility Center Subang Jaya Hospital, Subang
10.3.7.2 Concept Fertility Center
10.3.7.3 TMC Fertility Center

10.4 Indonesia embryo transfer market

10.4.1 Indonesia embryo transfer market by end users
10.4.2 Indonesia embryo transfer market by cycle type
10.4.3 Drivers

10.4.3.1 Increase in disposable income
10.4.3.2 Advances in embryo transfer technology
10.4.3.3 Decline in fertility rate

10.4.4 Restraints

10.4.4.1 Physical and emotional impact due to low success rate

10.4.5 Regulatory issues, legislations and authorities
10.4.6 Insurance reimbursement scenario
10.4.7 Company profiles

10.4.7.1 Morula IVF
10.4.7.2 Yasmin IVF
10.4.7.3 Aster Fertility Clinic
10.4.7.4 Fertility Centre, Siloam Hospitals Surabana

10.5 Philippines embryo transfer market

10.5.1 Philippines embryo transfer market by end users
10.5.2 Philippines embryo transfer market by cycle type
10.5.3 Drivers

10.5.3.1 Improve the replacement population
10.5.3.2 Advancement in technology

10.5.4 Restraints of embryo transfer market in Philippines
10.5.5 Regulatory issues, legislations and authorities
10.5.6 Insurance reimbursement scenario
10.5.7 Company Profiles

10.5.7.1 Victory Art Lab
10.5.7.2 CRM-MIA-Philippines

10.6 Thailand embryo transfer market

10.6.1 Thailand embryo transfer market by end users
10.6.2 Thailand embryo transfer market by cycle type
10.6.3 Drivers

10.6.3.1 Government initiatives
10.6.3.2 Surrogacy is economical as compared to developed countries
10.6.3.3 Boost in medical tourism

10.6.4 Restraints of embryo transfer in Thailand

10.6.4.1 Comparatively low success rate
10.6.4.2 Ethical issues in allowing gender selection

10.6.5 Regulatory issues, legislations and authorities
10.6.6 Insurance reimbursement scenario
10.6.7 Company Profiles

10.6.7.1 Bangkok Fertility Center
10.6.7.2 Siriraj Hospital
10.6.7.3 Ramathibodi Hospital
10.6.7.4 Perfect Woman Institute Piyavate Hospital
10.6.7.5 Jetanin Institute for Assisted Reproduction

10.7 Vietnam embryo transfer market

10.7.1 Vietnam embryo transfer market by end users
10.7.2 Vietnam embryo transfer market by cycle type
10.7.3 Drivers

10.7.3.1 Decline in fertility rate
10.7.3.2 Reasonable cost and good success rate

10.7.4 Restraints of the embryo transfer market in Vietnam
10.7.5 Regulatory issues, legislations and authorities
10.7.6 Insurance reimbursement scenario
10.7.7 Company Profiles

10.7.7.1 IVF Lab Tu Du Hospital Vietnam
10.7.7.2 IVF Van Hanh
10.7.7.3 IVFAS
10.7.7.4 Tu Du - Ho Chi Minh City Vietnam

10.8 Others embryo transfer market

10.8.1 Others embryo transfer market by end users

Table 1 Asia Pacific IVF Cycles Market Volume, By Country, 2014 2020 (Thousand)
Table 2 Asia Pacific Embryo Transfer Market Volume, By Country, 2014 2020 (Thousand)
Table 3 Asia Pacific Embryo Transfer Market Revenue, By Country, 2014 2020 ($Million)
Table 4 Asia-Pacific Fresh Embryo Transfer Market Volume, By Country, 2014 2020 (Thousand)
Table 5 Asia-Pacific Fresh Embryo Transfer Market Revenue, By Country, 2014 2020 ($Million)
Table 6 Asia-Pacific Frozen Embryo Transfer Market Volume, By Country, 2014 2020 (Thousand)
Table 7 Asia-Pacific Frozen Embryo Transfer Market Revenue, By Country, 2014 2020 ($Million)
Table 8 Asia Pacific Embryo Transfer Market Volume, By End User, 2014 2020 (Thousand)
Table 9 Asia Pacific Embryo Transfer Market Revenue, By End User, 2014 2020 ($Million)
Table 10 Asia-Pacific Embryo Transfer Market Volume, By Cycle Type, 2014-2020 (Thousand)
Table 11 Asia-Pacific Embryo Transfer Market Revenue, By Cycle Type, 2014-2020 ($Million)
Table 12 Thermo Fisher Scientific Inc. Business Overview
Table 13 Company Snapshot
Table 14 Emd Serono Inc Business Overview
Table 15 Company Snapshot
Table 16 China Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 17 China Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 18 China Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 19 China Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 20 Cook Medical Inc Business Overview
Table 21 Company Snapshot
Table 22 Vitrolife Ab Inc Business Overview
Table 23 Company Snapshot
Table 24 India Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 25 India Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 26 India Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 27 India Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 28 Sun Pharmaceutical Business Overview
Table 29 Company Snapshot
Table 30 Trivector Origio Scientific Business Overview
Table 31 Company Snapshot
Table 32 Lab Ivf Asia Business Overview
Table 33 Company Snapshot
Table 34 LG Life Science Business Overview
Table 35 Company Snapshot
Table 36 Cadila Health Care Business Overview
Table 37 Company Snapshot
Table 38 Korea Embryo Transfer Market Volume, By End User, 2014-2020 (Thousand)
Table 39 Korea Embryo Transfer Market Revenue, By End User, 2014-2020 ($Million)
Table 40 Korea Embryo Transfer Market Volume, By Cycle Type, 2014-2020 (Thousand)
Table 41 Korea Embryo Transfer Market Revenue, By Cycle Type, 2014-2020 ($Million)
Table 42 New Zealand Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 43 New Zealand Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 44 New Zealand Embryo Transfer Market, By Cycle Type, 2014-2020 ($Million)
Table 45 New Zealand Embryo Transfer Market, By Cycle Type, 2014-2020 (Thousand)
Table 46 Australia Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 47 Australia Embryo Transfers Market Revenue By End Users, 2014 2020 ($Million)
Table 48 Australia Embryo Transfer Market Volume, By Cycle Type, 2014-2020 (Thousand)
Table 49 Australia Embryo Transfer Market Revenue, By Cycle Type, 2014-2020 ($Million)
Table 50 Genea Biomedx Technologies Business Overview
Table 51 Company Snapshot
Table 52 Thermo Fisher Scientific Inc Business Overview
Table 53 Company Snapshot
Table 54 Japan Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 55 Japan Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 56 Japan Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 57 Japan Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 58 Emd Serono Inc Business Overview
Table 59 Company Snapshot
Table 60 Total Fertility Rate Of South-East Asia Country Per Thousand, 2015
Table 61 South-East Asia Embryo Transfer Market Volume, By Country, 2014 2020 (Thousand)
Table 62 South-East Asia Embryo Transfer Market Revenue, By Country, 2014 2020 ($Million)
Table 63 Singapore Embryo Transfer Market Volume, By End User, 2014 2020 (Thousand)
Table 64 Singapore Embryo Transfer Market Revenue, By End User, 2014 2020 ($Million)
Table 65 Singapore Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 66 Singapore Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 67 Irvine Scientific Business Overview
Table 68 Company Snapshot
Table 69 Esco Technologies Business Overview
Table 70 Company Snapshot
Table 71 Leica Microsystems Gmbh Business Overview
Table 72 Malaysia Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 73 Malaysia Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 74 Malaysia Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 75 Malaysia Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 76 Indonesia Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 77 Indonesia Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 78 Indonesia Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 79 Indonesia Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 80 Philippines Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 81 Philippines Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 82 Philippines Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 83 Philippines Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 84 Thailand Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 85 Thailand Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 86 Thailand Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 87 Thailand Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 88 Vietnam Embryo Transfer Market Volume, By End Users, 2014 2020 (Thousand)
Table 89 Vietnam Embryo Transfer Market Revenue, By End Users, 2014 2020 ($Million)
Table 90 Vietnam Embryo Transfer Market Volume, By Cycle Type, 2014 2020 (Thousand)
Table 91 Vietnam Embryo Transfer Market Revenue, By Cycle Type, 2014 2020 ($Million)
Table 92 Others Embryo Transfer Market Volume, By End Users, 2014-2020 (Thousand)
Table 93 Others Embryo Transfer Market Revenue, By End Users, 2014-2020 ($Million)
Table 94 Embryo Transfer Cost Per Cycle By Country (2014)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Aster Fertility Clinic
  • City Fertility
  • IVF Namba Clinic
  • Iwaki Womens Clinic
  • Manipal Ankur
  • Ramathibodi Hospital
  • MORE
A new report titled, “Asia-Pacific In-Vitro Fertilization Services Market—Opportunities and Forecasts, 2014–2020,” forecasts that the market is expected to generate a revenue of $3.5 billion by 2020. In 2015, Japan, China, and India were the prime destinations for IVF treatment, accounting for three-fourths of the overall market revenue. This is mainly attributed to factors such as large consumer base, economic cost of treatment, increasing popularity of medical tourism destinations, and availability of skilled workforce.

The major factors driving the growth of the Asia-Pacific IVF fertilization services market include rapidly increasing infertility rates, economic pricing, and increasing trend of delaying pregnancy among couples. In addition, countries with low birth rates, such as Indonesia, Vietnam, and Cambodia, are focused on improving the fertility rates to maintain a balance between the young and geriatric population. Moreover, increase in disposable incomes and growing health awareness are the key factors boosting the market growth. Promotional offers, such as accommodation and hospitality services by IVF centers and higher success rate of fertility treatment attract overseas patients to undergo IVF treatment supplement the market growth. Moreover, collaborations between academic institutions and fertility clinics & hospitals would foster the process of technological advancements in IVF technologies and facilitate better and effective IVF services. Furthermore, commercial adoption of high-end technologies and deployment of skilled workforce have fostered the growth of IVF services in the Asia-Pacific region. However, low health awareness in developing and underdeveloped countries, lack of favorable IVF reimbursement policies, and ethical & legal issues related to parental rights are likely to restrict the market growth.

In the current market scenario, fertility clinics are the leading end-users of the IVF services market, and this segment is expected to dominate the market during the forecast period. This is mainly attributed to the upsurge in hospital footfall and minimal patient waiting time for treatment. Furthermore, higher success rate and diversified offerings to patients promote the growth of the IVF fertility clinics and hospitals.

Key findings of the study:

- Fertility clinics segment accounts for 54.1% of the market revenue in the Asia-Pacific IVF services market.
- Clinical research institutes would emerge as the fastest growing end-user segment, registering a CAGR of 12.1% during the forecast period.
- In 2014, fresh IVF cycles segment held about two-thirds share of the overall market, and is expected to emerge as the fastest growing segment, registering a CAGR of 11.0% during 2015–2020.
- In terms of value, Japan accounted for one-thirds share of the overall market revenue in 2014. However, India is forecast to emerge as the fastest growing country, registering a CAGR of 14.7% during the forecast period.
- In term of volume, Japan, India and China collectively accounted for about three-fourth market share in 2015, and is anticipated to maintain this trend during the study period.

The key fertility clinics and centers profiled in this reports include Shenyang Hospital, Shandong Provincial Hospital, Nova IVI Fertility, Bloom Fertility Center, Bourn Hall Clinic, Virtus Health, Monash IVF, Flinders Fertility, and IVF Namba Clinic, among others. The leading companies profiled in this report are Thermo Fisher Scientific, Inc., EMD Serono, Inc., Sun Pharmaceutical, Cadila Healthcare Ltd., LG Life Sciences, Cook Medical, Inc., and Vitrolife AB.
Note: Product cover images may vary from those shown
5 of 5
- Aster Fertility Clinic
- Bloom Fertility Center
- Bourn Hall Clinic
- CRM-MIA-PhilippinesBangkok Fertility Center
- Cadila Healthcare Ltd. (Zydus Cadila group)
- Centre for Reproductive Medicine
- City Fertility
- CloudnineFertility Associates
- Concept Fertility Center
- EMD Serono, Inc.Cook Medical, Inc.
- Fertility Centre, Siloam Hospitals SurabanaVictory Art Lab
- Fertility Plus
- Flinders FertilityEMD Serono, Inc.
- IVF Namba Clinic
- IVF Van Hanh
- IVFAS
- Iwaki Womens Clinic
- Jetanin Institute for Assisted ReproductionIVF Lab Tu Du Hospital Vietnam
- LG Life Sciences.
- Lab IVF Asia Pte. Ltd.
- Manipal Ankur
- Monash IVF
- Morpheus IVF Fertility Center
- Mount Elizabeth Fertility Center
- Nova IVI Fertility
- Perfect Woman Institute Piyavate Hospital
- Raffles Fertility CentreSubang Fertility Center Subang Jaya Hospital, Subang
- Ramathibodi Hospital
- Reporomed Genea Biomedx
- Reproductive and genetic Hospital Citic-Xiangya
- Sanno Hospital NUH IVF Centre
- Shandong Provincial Hospital5.7.1 Sun Pharmaceutical Industries Ltd.
- Shenyang Hospital
- Siriraj Hospital
- Southend Fertility and IVF Centre
- TMC Fertility CenterMorula IVF
- Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc.
- Thomson Fertility Centre
- Trivector Origio Scientific Pvt. Ltd
- Tu Du - Ho Chi Minh City Vietnam
- Virtus Health
- Vitrolife AB
- Yasmin IVF

Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll